ProQR Therapeutics (PRQR) Short term Debt (2021 - 2024)
Historic Short term Debt for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $4.9 million.
- ProQR Therapeutics' Short term Debt changed N/A to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is N/A changed from last year.
- As of Q4 2024, ProQR Therapeutics' Short term Debt stood at $4.9 million.
- Over the past 5 years, ProQR Therapeutics' Short term Debt peaked at $43.1 million during Q1 2022, and registered a low of $19910.1 during Q1 2021.
- For the 4-year period, ProQR Therapeutics' Short term Debt averaged around $12.8 million, with its median value being $4.9 million (2022).
- As far as peak fluctuations go, ProQR Therapeutics' Short term Debt soared by 21618109.17% in 2022, and later crashed by 9034.26% in 2023.
- Quarter analysis of 4 years shows ProQR Therapeutics' Short term Debt stood at $5.5 million in 2021, then tumbled by 53.27% to $2.6 million in 2022, then grew by 23.39% to $3.1 million in 2023, then surged by 55.58% to $4.9 million in 2024.
- Its Short term Debt stands at $4.9 million for Q4 2024, versus $3.1 million for Q3 2023 and $3.9 million for Q2 2023.